Opening a testosterone replacement therapy clinic requires navigating medical licensing, DEA registration, clinical protocols, and a business model that can sustain itself in a competitive cash-pay market. Total startup costs typically range from $150,000 to $300,000 depending on whether you build out a full brick-and-mortar facility or lean into telehealth. Here’s what each step actually involves.
Choose a Business Model First
The two dominant models in the TRT space are cash-pay subscription clinics and insurance-based practices, and your choice shapes nearly every decision that follows. Most successful TRT clinics today operate on a cash-pay subscription model, where patients pay a flat monthly fee that bundles consultations, lab work, and medications. Subscription pricing at established clinics typically runs $129 to $199 per month, plus medication costs that range from $28 to $100 per month for injectable testosterone. This model avoids the overhead and delays of insurance billing, and it appeals to patients who want streamlined access.
Insurance-based billing is possible but more complex. You’ll need credentialing with payers, a dedicated billing team or service, and patience for reimbursement timelines. Many TRT clinics avoid insurance entirely because the margins are tighter and the administrative burden is substantial. If you do accept insurance, expect that patients with high-deductible plans will still pay $200 to $600 out of pocket for a single office visit and blood work.
A hybrid approach works too: accept insurance for initial diagnostic labs and consultations, then offer a cash-pay optimization program for ongoing monitoring and prescriptions.
Licensing, DEA Registration, and Legal Structure
Testosterone is a Schedule III controlled substance, which means you need a licensed prescriber and a DEA registration to operate. If you’re not a physician yourself, you’ll need to hire or partner with one. In many states, nurse practitioners and physician assistants can prescribe testosterone independently or under a collaborative practice agreement, but the rules vary significantly by state. Check your state medical board’s scope-of-practice laws before building your staffing plan.
Every prescriber in the clinic needs their own individual DEA registration. The clinic itself may also need a separate DEA registration if it stores or dispenses controlled substances on-site. Apply early, because DEA processing can take several weeks.
Beyond the DEA, you’ll need a state medical facility license, a business entity (LLC or PLLC depending on your state), malpractice insurance, and compliance with HIPAA privacy rules. Malpractice insurance for a TRT clinic runs approximately $3,800 per month. State licensing fees add roughly $1,200 per month for professional board compliance. Budget $5,000 to $15,000 upfront for the first few months of regulatory and insurance costs combined.
Telehealth vs. Brick-and-Mortar
The DEA, jointly with HHS, has extended telemedicine prescribing flexibilities through December 31, 2026. This means a DEA-registered practitioner can prescribe Schedule II through V controlled substances, including testosterone, via telehealth without an in-person evaluation, provided certain conditions are met. This creates a viable path for launching a telehealth-first TRT clinic with significantly lower overhead.
A telehealth model eliminates the need for a physical exam room, on-site lab equipment, and most medical supplies. Patients complete blood work at a partner lab (Quest, Labcorp, or a local draw site), then consult with your provider via video. Medications ship directly to the patient. This model can launch for under $100,000 when you factor in EMR software, telehealth platform licensing, initial marketing, and legal setup.
A brick-and-mortar clinic offers advantages in patient trust, the ability to perform in-office injections (which many patients prefer), and on-site phlebotomy. But the costs are higher. Diagnostic laboratory equipment runs around $85,000. Initial medical supplies and hormone inventory require roughly $40,000. EMR software setup costs about $15,000. Add lease buildout, furniture, and signage, and you’re looking at $200,000 or more before seeing your first patient.
Clinical Protocols and Diagnostic Standards
Your clinic’s credibility depends on following established diagnostic criteria. The Endocrine Society’s guidelines define the normal range for total testosterone as 270 to 890 ng/dL, measured from a morning blood draw. A diagnosis of hypogonadism requires two separate morning blood tests showing low levels, combined with clinical symptoms like decreased libido, fatigue, loss of muscle mass, or osteopenia. You cannot ethically or legally prescribe testosterone based on symptoms alone or a single lab result.
Before starting any patient on therapy, baseline labs should include total testosterone, hematocrit, and prostate-specific antigen (PSA). Some clinics also run calculated bioavailable testosterone (which accounts for the protein that binds testosterone in the blood), a metabolic panel, and lipid levels. These baselines protect the patient and protect your clinic legally.
Monitoring protocols follow a predictable schedule. Repeat hematocrit, PSA, and testosterone levels at three months and six months after starting therapy, then annually if values are stable. The timing of the blood draw matters depending on the delivery method: for injectable testosterone cypionate or enanthate, draw blood either midway between injections or at the lowest point before the next injection. For topical gels, draw two to eight hours after application. For oral testosterone undecanoate, draw three to five hours after the patient takes it with a fat-containing meal.
Contraindications You Must Screen For
Certain patients cannot receive testosterone, and your intake process needs to catch them. Absolute contraindications include untreated prostate cancer and breast cancer in men. High-risk patients, including those with first-degree relatives who had prostate cancer and African American men with a PSA above 3 ng/dL, require careful evaluation before proceeding.
Hematocrit is the lab value that will most commonly interrupt treatment. If a patient’s hematocrit rises above 54% while on therapy, testosterone must be paused until it normalizes. This happens more often than new clinic owners expect, so build a protocol for managing it, including therapeutic phlebotomy referrals or dose adjustments. Sleep apnea remains a relative contraindication, meaning it doesn’t automatically disqualify a patient but requires extra monitoring and clinical judgment.
Storage and Inventory Management
Injectable testosterone cypionate, the most commonly prescribed form, is simpler to store than many clinic owners assume. It requires controlled room temperature storage between 68°F and 77°F and protection from light. You do not need medical-grade refrigeration for testosterone cypionate itself. However, if you plan to stock ancillary medications like HCG (commonly used alongside TRT to maintain fertility), those do require refrigeration. Budget around $12,000 for medical-grade refrigeration units if your protocol includes temperature-sensitive compounds.
Keep your initial hormone and supply inventory lean. $40,000 covers a reasonable starting stock for a clinic seeing 50 to 100 patients in its first few months. Track expiration dates carefully, since overstocking controlled substances creates both financial waste and regulatory risk.
Marketing Without Crossing Regulatory Lines
The FDA has made it clear that testosterone is approved solely for men who have low testosterone in conjunction with an associated medical condition. Marketing that implies testosterone is an anti-aging treatment, a performance enhancer, or a solution for age-related decline puts your clinic at regulatory risk. The FDA specifically retains “Limitation of Use” language for age-related hypogonadism, meaning you cannot frame normal aging as a disease that testosterone treats.
Your marketing materials should also disclose known risks. The FDA now requires warnings about increased blood pressure across all testosterone products. Advertising that emphasizes benefits without mentioning risks can trigger enforcement action. Stick to language about treating clinically diagnosed low testosterone, improving quality of life for men with hypogonadism, and restoring levels to a healthy range with proper medical supervision.
In practice, most TRT clinics acquire patients through search engine optimization, Google Ads targeting local “low testosterone” searches, and social media content that educates rather than sells. Patient referrals become the dominant growth channel once you reach 100 to 150 active patients, so invest heavily in the patient experience from day one.
Staffing and Day-to-Day Operations
A lean TRT clinic can operate with a licensed prescriber (physician, NP, or PA), a medical assistant or phlebotomist, and an office manager who handles scheduling and billing. If you’re running a cash-pay model, you can skip the billing specialist entirely and use your EMR’s built-in payment processing. As volume grows past 200 active patients, add a second provider and a patient coordinator to handle lab follow-ups and refill requests.
The daily workflow is straightforward compared to most medical practices. New patients complete intake paperwork, get labs drawn (on-site or at a partner lab), and return for a consultation once results are in. Follow-up visits are brief: review labs, assess symptoms, adjust dosing if needed. Many follow-ups can happen via telehealth even in a brick-and-mortar clinic, freeing up exam room time for new patients and in-office injections.
Most TRT clinics reach profitability within 12 to 18 months, assuming a cash-pay subscription model and steady patient acquisition of 15 to 25 new patients per month. The recurring revenue structure is the key financial advantage: once a patient starts therapy, they typically remain on it long-term, creating predictable monthly income that compounds as your patient base grows.